Alexandra Schafer - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Alexandra Schafer's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Alexandra Schafer
Verified
Earth
Beats
Biography
VELVENOIR – international contemporary art consultancy and gallery. Managed by Alexandra Schafer, who brings her passion for art into the company. VELVENOIR delivers a full range of art consultancy services to the hospitality, residential, commercial and development design industry as well as assists private collectors to start their own contemporary art collection. Alexandra Schafer grew up in Salzburg, Austria and has been traveling with her family throughout her childhood before studying and working within the event & hospitality industry in London and Sydney. Alexandra´s exposure to richly diverse cultures informs her entire approach and unique ability to translate each client´s desire into a tailored art collection proposed by her and her team. She gained invaluable experiences and insights throughout her years living in London and Sydney and brings those unique elements and inspirations within her work today. Throughout the years, she worked for companies such as Four Seasons, David Jones, Merivale, HSBC, Sportsworld, The Star Sydney and many other boutique hotels. A clear understanding and passion for international collaborations have led Alexandra to partner with the best in class experts across the globe, who share believe that there is a unique connection only original art can contribute to the property! A network, which allows her to bring in experts when needed but also supports her to curate and grow the outstanding art collection VELVENOIR has to offer for their international partners and clients. Now, VELVENOIR offers an international network, individual firms working on various projects and whenever required each firm partners within the network, to ensure an outstanding outcome for all our projects. The network, consist from art consultants, advisors to curators that are based in various countries, but their passion for art has brought them together, to create a unique art experience for clients around the world.
fashion, technology, apps
Content
By Sofie Jacobs, Jordi Doijen, Rana Abdelnabi, Michiel Van Gool, Alexandra Schafer, Dirk Jochmans, Steven De Jonghe, Pieter Leyssen, Winston Chiu, Frank Jacobs, Amanda Del Rosario, Johan Neyts, Ralph S Baric, Eric J. Snijder, Sujata Sharma, Ruxandra Draghia-Akli, Anil Koul, Mandeep Kaur Mann| Nature Verified AbstractThe membrane (M) protein of betacoronaviruses is well conserved and has a key role in viral assembly1,2. Here we describe the identification of JNJ-9676, a small-molecule inhibitor targeting the coronavirus M protein. JNJ-9676 demonstrates in vitro nanomolar antiviral activity against SARS-CoV-2, SARS-CoV and sarbecovirus strains from bat and pangolin zoonotic origin.
By Kaitlin R Sprouse, Marcos Miranda, Nicholas J. Catanzaro, Amin Addetia, Cameron Stewart Verified, Jack Brown, Annie M. Dosey, Adian Valdez, Rashmi Ravichandran, Maggie Ahlrichs, Craig L. Dobbins, Alexis Hand, Catherine Treichel, Alexandra C. Walls, Andrew McGuire, Elizabeth M. Leaf, Ralph S Baric, Alexandra Schafer, David Veesler, Neil King, Cara W. Chao, Miranda L. Hubbard, Grace G. Hendricks, Jackson McGowan, Isabelle Willoughby| Cell Reports Verified KeywordsMERS-CoVEMPEMnanoparticlevaccineRBDNTDspikeResearch topic(s)CP: ImmunologyIntroductionThe recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has demonstrated the human and economic toll that can accompany the spillover and spread of a zoonotic disease in humans. Although the success of vaccine development efforts in response to the pandemic were a triumph of modern vaccinology, SARS-CoV-2 remains the only coronavirus for which licensed vaccines are available.
By Sharon Saydah, Michael J Peluso, Julio César Silva, Júlio Silva, Alexandra Schafer| Science Magazine Verified AbstractThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) pandemic has caused more than 7 million deaths globally. Despite the presence of infection- and vaccine-induced immunity, SARS-CoV-2 infections remain a major global health concern because of the emergence of SARS-CoV-2 variants that can cause severe acute coronavirus disease 2019 (COVID-19) or enhance Long Covid disease phenotypes.
Company Info
Chapel Hill, North Carolina, United States
+1 919-962-1208